ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Chloroquine’s Effect on T cell Proliferation

R. Muschalek1, P. Jindra2, R. Kerman2, M. Kueht2, W. Etheridge2, M. Cusick2

1Baylor College of Medicine, Houston, TX, 2Department of Surgery, Baylor College of Medicine, Houston, TX

Meeting: 2019 American Transplant Congress

Abstract number: A269

Keywords: CD3

Session Information

Session Name: Poster Session A: Kidney Immunosuppression: Novel Regimens and Drug Minimization

Session Type: Poster Session

Date: Saturday, June 1, 2019

Session Time: 5:30pm-7:30pm

 Presentation Time: 5:30pm-7:30pm

Location: Hall C & D

*Purpose: An anti-malarial agent, Chloroquine (CQ), has been widely used for the treatment of rheumatoid arthritis and lupus. Although the precise mechanisms of CQ are not well understood, CQ may reduce peptide-MHCII protein cellular expression. One result of this downregulation is the modulation of effector CD4+ T cell response. Because this mechanism differs from other anti-rejection drugs, CQ could be well suited to supplement current immunosuppressive regimens. However, there is very little insight into the effect of CQ directly inhibiting T cell proliferation. In this study, we used human in vitro assays to assess the ability of CQ to directly inhibit T cell proliferation.

*Methods: Blood was collected in acid citrate dextrose and peripheral blood mononuclear cells (PBMCs) were isolated by ficoll-hypaque gradient centrifugation. PBMCs were labeled with a cell trace dye and stimulated with CD3/28 dynabeads (non-specific activator of T cells). Medium control well was untreated PBMCs. PBMCs were treated with increasing concentrations CQ at 1, 3, 10, or 30 μM. After 5-7 days in culture, PBMCs were stained with 7-Amino-Actinomycin D (7-AAD), CD3-AmCyan, CD4-phycoerythrin, and CD8- allophycocyanin and analyzed on a BD fluorescence-activated cell sorting Canto II.

*Results: Figure 1: Inhibition of CD4+ & CD8+ T Cells with increasing concentration of CQ. Errors bars indicate standard error of the measurement

*Conclusions: These preliminary results demonstrate CQ inhibiting T cell proliferation in a dose-dependent manner. The frequency of T cell proliferation is still high at a concentration of 3uM suggesting the drug is not inhibiting T cell proliferation directly. The decrease in T cell proliferation at higher concentrations appears to be associated with toxicity of the drug as indicated by the increased frequency of dead cells (7-AAD+). Current investigation is directed towards determining CQ’s impact on MHC expression using human in vitro assays and monitoring transplant patients currently on CQ.

 border=

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Muschalek R, Jindra P, Kerman R, Kueht M, Etheridge W, Cusick M. Chloroquine’s Effect on T cell Proliferation [abstract]. Am J Transplant. 2019; 19 (suppl 3). https://atcmeetingabstracts.com/abstract/chloroquines-effect-on-t-cell-proliferation/. Accessed May 11, 2025.

« Back to 2019 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences